Comparison of Length of Treatment and Comorbidities in Older and Adult Hospitalized Patients with Bacterial Community-Acquired Pneumonia

Background: Among the 1 017 290 people surveyed, the prevalence of pneumonia was 2.5% in the 55-64 age group, 3.0% in the 65-74 age group, and 2.9% in those aged 75 years and older. This indicates an increase in pneumonia prevalence from 1.8% to 2% in Indonesia. This study aimed to compare the length of treatment and comorbidities in older and adult patients with community-acquired pneumonia at Jakarta Sukapura Islamic Hospital and Jakarta Pondok Kopi Islamic Hospital between September 2022 and September 2024.

Methods: This was a comparative study with a cross-sectional design, and secondary data from 244 patient samples were used.

Results: Among adult patients, 101 had a length of treatment of ≤5 days, whereas 17 had a length of treatment of >5 days. Among older patients, 67 had a length of treatment of ≤5 days, whereas 59 had a length of treatment of >5 days. Comorbidities were absent in 69 adult and 45 older patients. A total of 49 adult patients and 81 older patients had comorbidities.

Conclusion: Older patients with community-acquired pneumonia had a longer treatment duration and more comorbidities than adult patients with bacterial community-acquired pneumonia.

Cite this article as: Fachri M, Hatta M, Zakia D, et al. Comparison of length of treatment and comorbidities in older and adult hospitalized patients with bacterial community-acquired pneumonia. Eurasian J Med. 2025; 57(3), 0910, doi: 10.5152/ eurasianjmed.2025.25910.